Finally Recombinant Human Ush1c/harmonin Protein (his Tag) System [aArqFhDR]

Finally Recombinant Human Ush1c/harmonin Protein (his Tag) System [aArqFhDR]

Introducing our premium Finally Recombinant Human Ush1c/harmonin Protein (his Tag) System [aArqFhDR], a high-quality product designed for research purposes. This protein, derived from E.coli expression host, is a crucial component for understanding and studying Usher syndrome type 1C (USH1C), a genetically heterogeneous condition characterized by retinitis pigmentosa and sensorineural deafness. The USH1C protein contains 3PDZ (DHR) domains, making it an essential tool for researchers exploring protein-protein interactions.

Product Properties and Specifications

Our Finally Recombinant Human Ush1c/harmonin Protein (his Tag) System [aArqFhDR] is carefully formulated to ensure optimal performance in your research. This protein has a purity of greater than 92% as determined by reducing SDS-PAGE, guaranteeing the highest level of quality. It is also available in a lyophilized powder form, shipped with ice packs to ensure its integrity during transit. The protein has a calculated molecular weight of 63.7 kDa and an observed molecular weight of 63.7 kDa, making it ideal for various research applications. Below are some key properties and specifications:

• Purity: > 92% as determined by reducing SDS-PAGE.
• Expression Host: E.coli.
• Sequence: Met 1-Phe 552.
• Accession: Q9Y6N9-1.
• Tag: N-His.

Practical Uses and Benefits

Our Finally Recombinant Human Ush1c/harmonin Protein (his Tag) System [aArqFhDR] is an invaluable tool for researchers studying Usher syndrome type 1C and related conditions. The protein's unique properties make it ideal for a variety of applications, including:

• Understanding the molecular basis of Usher syndrome type 1C.
• Investigating protein-protein interactions in the context of USH1C.
• Developing potential therapies for USH1C and related hearing loss conditions.

This high-quality protein is a must-have for researchers in the fields of genetics, ophthalmology, and audiology, offering numerous benefits for advancing our understanding of these complex conditions.